Coronavirus Vaccines: Identifying Ways to Build Public Trust
This article was originally published in The Conversation on Nov. 4, 2020. The article was written by University of Florida College of Journalism and Communications Center for Public Interest Communications Director Ann Christiano and Post-doctoral Research Associate Jack Barry.
The pharmaceutical companies Pfizer and BioNtech announced Nov. 20, 2020, that they will seek emergency use authorization from the Food and Drug Administration for a vaccine to prevent COVID-19. On Nov. 16, Moderna announced that a vaccine it has been working on has been shown to be close to 95% effective.
But no vaccine will be nearly that effective in reality if people refuse to take it. And recent polls suggest that about 40% of Americans won’t take a COVID-19 vaccine when it becomes available. Those numbers are even higher among nonwhite Americans.
Posted: January 27, 2021
Category: Center Update